In addition, genetic and/or pharmacologic reduction of ATM reduced doxorubicin-induced cardiotoxicity and rescued cardiac inflammation and heart failure caused by DNA single-strand breaks [74, 75]. The gene discussed is ATM; the disease is heart failure.